Matches in Wikidata for { <http://www.wikidata.org/entity/Q92068239> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q92068239 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q92068239 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92068239 description "scientific article published on 27 February 2019" @default.
- Q92068239 description "wetenschappelijk artikel" @default.
- Q92068239 description "наукова стаття, опублікована в лютому 2019" @default.
- Q92068239 name "Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients" @default.
- Q92068239 name "Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients" @default.
- Q92068239 type Item @default.
- Q92068239 label "Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients" @default.
- Q92068239 label "Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients" @default.
- Q92068239 prefLabel "Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients" @default.
- Q92068239 prefLabel "Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients" @default.
- Q92068239 P1433 Q92068239-76E95EBC-34E5-47D5-9086-DF390B354415 @default.
- Q92068239 P1476 Q92068239-D8D5A7AE-7F14-4688-9637-7D8DBC2D0E51 @default.
- Q92068239 P2093 Q92068239-07A948FD-7C27-486E-9C10-53C3CD7C5D42 @default.
- Q92068239 P2093 Q92068239-15F7069C-AFCA-4A70-B2CD-7F820B4F660E @default.
- Q92068239 P2093 Q92068239-5E95F640-3467-496F-8CD0-595EB582C62F @default.
- Q92068239 P2093 Q92068239-980F3017-CDF6-4370-B99D-72256660FCD4 @default.
- Q92068239 P2093 Q92068239-F8B20FEB-AD9B-431D-B0F0-39A3B14036F6 @default.
- Q92068239 P31 Q92068239-04B787FD-354B-4E12-B205-0D6D28F379C6 @default.
- Q92068239 P356 Q92068239-C38629A2-C551-4EC9-AC60-0319E501C008 @default.
- Q92068239 P577 Q92068239-59233DFD-F9D9-4B6D-8C12-9E43324B2ACE @default.
- Q92068239 P698 Q92068239-5D7571A8-AB03-4EB6-A3FD-C82AAF65B8B6 @default.
- Q92068239 P921 Q92068239-F4899196-4DA1-46EE-A94E-194C6B86836C @default.
- Q92068239 P356 J.JAAD.2019.01.091 @default.
- Q92068239 P698 30825531 @default.
- Q92068239 P1433 Q15757046 @default.
- Q92068239 P1476 "Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients" @default.
- Q92068239 P2093 "Anand Rajpara" @default.
- Q92068239 P2093 "Brett C Neill" @default.
- Q92068239 P2093 "Daniel J Aires" @default.
- Q92068239 P2093 "Isadore S Tarantino" @default.
- Q92068239 P2093 "Spyros M Siscos" @default.
- Q92068239 P31 Q13442814 @default.
- Q92068239 P356 "10.1016/J.JAAD.2019.01.091" @default.
- Q92068239 P577 "2019-02-27T00:00:00Z" @default.
- Q92068239 P698 "30825531" @default.
- Q92068239 P921 Q422226 @default.